R
Rebecca Stowe
Researcher at University of Birmingham
Publications - 28
Citations - 6422
Rebecca Stowe is an academic researcher from University of Birmingham. The author has contributed to research in topics: Parkinson's disease & Levodopa. The author has an hindex of 21, co-authored 28 publications receiving 5594 citations.
Papers
More filters
Journal ArticleDOI
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
TL;DR: A systematic review of studies reporting LEDs yielded a standardized LED for each drug, providing a useful tool to express dose intensity of different antiparkinsonian drug regimens on a single scale.
Journal ArticleDOI
Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials
Richard Gray,Robert Kerrin Hills,Rebecca Stowe,Mike Clarke,Richard Peto,Marc Buyse,P. Piedbois +6 more
TL;DR: Overall survival would be moderately improved by use of preoperative radiotherapy, especially for young, high risk patients, and short preoperative radiation schedules seem to be at least as effective as longer schedules.
Journal ArticleDOI
Physiotherapy versus placebo or no intervention in Parkinson's disease
Claire L Tomlinson,Smitaa Patel,Charmaine Meek,Clare P Herd,Carl E Clarke,Rebecca Stowe,Laila Shah,Catherine Sackley,Katherine H O Deane,Keith Wheatley,Natalie Ives +10 more
TL;DR: Benefit for physiotherapy was found in most outcomes over the short term but was significant only for speed, two- or six-minute walk test, Freezing of Gait questionnaire, and clinician-rated disability using the Unified Parkinson's Disease Rating Scale.
Journal ArticleDOI
Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis.
Claire L Tomlinson,Smitaa Patel,Charmaine Meek,Clare P Herd,Carl E Clarke,Rebecca Stowe,Laila Shah,Catherine Sackley,Katherine H O Deane,Keith Wheatley,Natalie Ives +10 more
TL;DR: Systematic review and meta-analysis of randomised controlled trials found no evidence that the treatment effect differed across the interventions for any outcomes assessed, apart from motor subscores on the unified Parkinson’s disease rating scale.
Journal ArticleDOI
Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.
TL;DR: It is shown that although biochemotherapy clearly improves response rates, this does not appear to translate into a survival benefit.